Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

"We invest in promising new drugs, medical devices and medical tools from Stage II clinical trials and beyond up and through product approvals, commercialization, manufacturing and distribution through our Accelerator Program. We are keenly interested in biologics and experimental applications for difficult to treat diseases such as cancer, sickle cell anemia, and rheumatoid arthritis, as well as devices that ease drug delivery for chronic conditions such as diabetes and kidney disease or tools that enable new surgical procedures. We work with top intellectual property attorneys and specialist to gain the broadest patent protection possible."

Per IBIS Partners site. Creators of the Innovation and Equity 50 most...
"Templeton, chief economist for the Ibis Partners hedge fund based in West Palm Beach, is organizing a $100 million private equity pool to support a number of ready to launch technologies developed by 50 Most selectees and participants"
Commissiongs are "2" of the "50".

http://www.ibispartners.com/biotechnology.html

Hmm, if only Amarantus had a phase 2 candidate....<sarcasm>